Per Wold-Olsen is a Norwegian businessperson who has been the head of 8 different companies. Currently, he is Chairman at GN Store Nord A, Chairman of GN Audio A, Chairman for GN Hearing An and Chairman for GN Netcom A (which are all subsidiaries of GN Store Nord A) and Chairman of Oncopeptides AB. He is also on the board of Gilead Sciences, Inc. and Bio Malter and Chairman of MMV Medicines for Malaria Venture.
He previously occupied the position of President-Intercontinental Division at Merck & Co., Inc. and Chief Executive Officer for MSD (Norge) AS (a subsidiary of Merck & Co., Inc.), Regional Director & Vice President at MSD Scandinavia AS and Chairman-Supervisory Board for H. Lundbeck A.
He received an MBA from the University of Wisconsin and an MBA from BI Norwegian Business School.